Celldex Therapeutics | CLDX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -5.94B 721M 2026-06
Agenus USD -199.08M 22.15M 2026-06
Amgen USD 11.69B 2.5B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Celldex Therapeutics USD 714.56M 258.34M 2026-06
Glaxosmithkline GBP 17.42B 4.64B 2026-03
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Northwest Biotherapeutics USD -50.54M 58.1M 2026-03
Pfizer USD 85.19B 4.91B 2026-06
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 32.69B 1.11B 2026-06